David George Putman

Title: David George Putman: Innovator in Pharmaceutical Sciences

Introduction

David George Putman is a notable inventor based in Stow, MA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target central nervous system disorders. With a total of five patents to his name, Putman has established himself as a key figure in innovation within the pharmaceutical industry.

Latest Patents

Among his latest patents is the development of enantiomerically pure S-etifoxine, which includes pharmaceutical compositions and methods for its use. This invention provides compounds that are effective in treating disorders associated with the central nervous system. Another significant patent involves the synthesis, polymorphs, and pharmaceutical formulation of FAAH inhibitors. This work highlights the pharmacological inhibition of fatty acid amide hydrolase (FAAH) activity, which leads to increased levels of fatty acid amides, showcasing Putman's expertise in drug formulation and development.

Career Highlights

Throughout his career, David George Putman has worked with prominent organizations such as Roche Palo Alto LLC and the University of California. His experience in these institutions has allowed him to collaborate on various innovative projects that have advanced the field of pharmaceuticals.

Collaborations

Putman has collaborated with notable colleagues, including Olivier Dasse and David Garrett Loughhead. These partnerships have contributed to the successful development of his patented inventions and have fostered a collaborative environment for innovation.

Conclusion

David George Putman is a distinguished inventor whose work in pharmaceutical sciences has led to significant advancements in the treatment of central nervous system disorders. His contributions through patents and collaborations reflect his commitment to innovation in the field.